AVONEX

Nchi: Israeli

Lugha: Kiingereza

Chanzo: Ministry of Health

Viambatanisho vya kazi:

INTERFERON BETA 1A 30 MCG/VIAL

Inapatikana kutoka:

MEDISON PHARMA LTD

ATC kanuni:

L03AB07

Dawa fomu:

POWDER FOR SOLUTION FOR INJECTION

Njia ya uendeshaji:

I.M

Viwandani na:

BIOGEN IDEC LTD, UK

Kundi la matibabu:

INTERFERON BETA-1A

Matibabu dalili:

Avonex is indicated for the treatment of relapsing forms of multiple sclerosis to slow the accumulation of physical disability and to decrease the frequency of clinical exacerbations. Avonex is also indicated for the treatment of patients who have experienced a single demyelinating event with an active inflammatory process if it is severe enough to warrant treatment with intravenous corticosteroids if alternative diagnosis have been excluded, including the prescence of MRI abnormalities characteristic of MS and if they are determined to be at high risk of developing clinically definite multiple sclerosis. Safety and efficacy in patients with chronic progressive multiple sclerosis has not been evaluated.

Idhini ya tarehe:

2011-11-01